MAGLIE, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.778
AS - Asia 3.504
EU - Europa 3.070
SA - Sud America 450
AF - Africa 70
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.919
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.701
RU - Federazione Russa 1.290
CN - Cina 1.115
SG - Singapore 971
IT - Italia 668
HK - Hong Kong 388
BR - Brasile 377
KR - Corea 349
IE - Irlanda 288
VN - Vietnam 262
DE - Germania 176
SE - Svezia 143
IN - India 125
FI - Finlandia 120
FR - Francia 107
PL - Polonia 107
BD - Bangladesh 79
GB - Regno Unito 65
JO - Giordania 50
AU - Australia 45
CA - Canada 44
ID - Indonesia 38
JP - Giappone 33
AR - Argentina 26
NG - Nigeria 20
MX - Messico 19
NL - Olanda 18
EC - Ecuador 17
UA - Ucraina 15
ES - Italia 12
IQ - Iraq 12
BJ - Benin 10
CH - Svizzera 10
PH - Filippine 10
PK - Pakistan 10
LT - Lituania 9
MK - Macedonia 9
AE - Emirati Arabi Uniti 8
AT - Austria 8
CI - Costa d'Avorio 8
ZA - Sudafrica 8
CO - Colombia 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
MA - Marocco 6
TR - Turchia 6
VE - Venezuela 6
IL - Israele 5
PY - Paraguay 5
TN - Tunisia 5
AZ - Azerbaigian 4
NO - Norvegia 4
NP - Nepal 4
PE - Perù 4
BG - Bulgaria 3
BO - Bolivia 3
CL - Cile 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
MY - Malesia 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AM - Armenia 2
BE - Belgio 2
EG - Egitto 2
GA - Gabon 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
ML - Mali 2
PA - Panama 2
RO - Romania 2
TW - Taiwan 2
UY - Uruguay 2
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
MM - Myanmar 1
MT - Malta 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
Totale 11.913
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.515
Singapore 713
Ashburn 484
Hefei 416
Seoul 346
Hong Kong 328
Dublin 284
Fairfield 222
Chandler 154
Milan 139
San Jose 136
Beijing 123
Council Bluffs 114
Moscow 111
Munich 104
Warsaw 102
Buffalo 101
Helsinki 90
Houston 90
Los Angeles 89
Seattle 89
Florence 84
Woodbridge 83
Ho Chi Minh City 78
Cambridge 77
Kent 72
Lauterbourg 64
Lawrence 63
Mumbai 63
Chicago 61
Wilmington 61
Altamura 57
The Dalles 57
Rome 56
Hanoi 55
Melbourne 43
New York 41
Princeton 35
Boston 32
Dallas 31
Jakarta 31
São Paulo 29
Ann Arbor 27
Paris 26
Shanghai 26
Frankfurt am Main 25
Tokyo 23
Bremen 21
Bengaluru 20
Boardman 20
Medford 20
Pune 20
Abuja 19
Clifton 19
Salt Lake City 19
Elk Grove Village 18
Rio de Janeiro 18
San Diego 18
West Jordan 18
Da Nang 14
Guangzhou 14
Lappeenranta 14
Orem 14
London 12
Norwalk 12
Secaucus 12
Montreal 11
Toronto 11
Brasília 10
Cardiff 10
Cotonou 10
Dong Ket 10
Naples 10
Palermo 10
Tampa 10
Turin 10
Bologna 9
Haiphong 9
Phoenix 9
Shenzhen 9
Abidjan 8
Figino 8
Guarulhos 8
Miano 8
Turku 8
Atlanta 7
Denver 7
Hillsboro 7
Hải Dương 7
Miami 7
Redondo Beach 7
Tianjin 7
Belo Horizonte 6
Bern 6
Brooklyn 6
Figline Valdarno 6
Gorlago 6
Manchester 6
Porto Alegre 6
Romola 6
Totale 7.647
Salva come PNG Salva come JPEG
Nome #
Interleukin-36 cytokines are overexpressed in the skin and sera of patients with bullous pemphigoid 314
miRNA-203b-3p induces acute and chronic pruritus via 5-HTR2B and TRPV4 303
Dermatitis Herpetiformis: Novel Perspectives 274
Anti-β4 integrin autoantibodies in patients with mucous membrane pemphigoid: a retrospective analysis from a tertiary centre in Italy 253
Squamous cell carcinoma developed after ingenol mebutate therapy: a possible consequence of the treatment? 216
Eosinophilic dermatosis of hematologic malignancy: A retrospective cohort of 37 patients from an Italian center 213
B-cell targeted therapies in pemphigus 210
Granular Deposits of IgA in the Skin of Coeliac Patients Without Dermatitis Herpetiformis: A Prospective Multicentric Analysis 205
Fatal occurrence of acquired haemophilia A in a patient with pemphigus vulgaris 196
Clinical Patterns, Survival, Comorbidities, and Treatment Regimens in 149 Patients With Pemphigus in Tuscany (Italy): A 12-Year Hospital-Based Study 195
Bullous eruption in a patient with B-cell chronic lymphocytic leukemia: a diagnostic challenge 194
Rituximab in Mucous Membrane Pemphigoid: A Monocentric Retrospective Study in 10 Patients with Severe/Refractory Disease 186
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review 184
Localized pemphigus exacerbation associated with underlying breast cancer 180
Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study 179
Case Report: Bullous Pemphigoid Associated With Morphea and Lichen Sclerosus: Coincidental Diseases or Pathogenetic Association? 173
T-Cell Response in Dermatitis Herpetiformis: May Epidermal Transglutaminase Play a Role in Predicting Clinical Relapse? 168
Dramatic exacerbation of bullous pemphigoid following rituximab and successful treatment with omalizumab 163
Alterations of circulating free fatty acids in patients with pemphigus vulgaris 162
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV) 161
Indirect immunofluorescence in mucous membrane pemphigoid: which substrate should be used? 159
Cutaneous eruptions associated with haematologic malignancies: the need for a unifying nomenclature 159
Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy 159
Dupilumab for the treatment of recalcitrant eosinophilic dermatosis of haematologic malignancy 159
A case of blood sweating: hematohidrosis syndrome 158
Lepromatous leprosy presenting with erythema nodosum leprosum mimicking Bechet's disease 158
Lichen planus triggered by CT-P13 and recurrence during secukinumab treatment 158
Response to "Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An Eosinophilic Dermatosis Predominantly Associated with Chronic Lymphocytic Leukemia". 157
Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience 154
Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab 153
At the Root: Cutaneous Langerhans Cell Histiocytosis. 153
Tralokinumab efficacy in a case of dupilumab-resistant severe atopic dermatitis complicated by eczema herpeticum 152
Is chemotherapy the best option for chronic lymphocytic leukemia associated Wells’ syndrome? Reply to “Case of Wells’ syndrome: A rare association with the clinical course of chronic lymphocytic leukemia” 151
Post-Surgical Anti-BP230 Bullous Pemphigoid: A Rare Cause of Non-Healing Wound 150
Rapid and sustained response to tralokinumab in a patient with severe bullous pemphigoid and end-stage kidney disease 149
Impressive response of erosive pustular dermatosis of the scalp to lymecycline monotherapy 149
Marie Antoinette syndrome following COVID-19 vaccination 148
Specific dermatoses of pregnancy other than pemphigoid gestationis 147
A giant annular rash in a woodman: the many faces of erythema chronicum migrans 144
Inverted-U serration pattern: a novel clue for the diagnosis of anti-laminin-γ1 pemphigoid 144
The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets 142
Human Desmocollin 3‒Specific IgG Antibodies Are Pathogenic in a Humanized HLA Class II Transgenic Mouse Model of Pemphigus 139
T helper type 1-related molecules as well as interleukin-15 are hyperexpressed in the skin lesions of patients with pyoderma gangrenosum 138
Myelodysplasia cutis as the presenting sign of chronic myelomonocytic leukaemia 138
Sweet syndrome following sars-cov2 vaccination 138
Corrigendum: S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV) 137
Folliculitis decalvans with exclusive beard involvement 137
Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry 135
Comment on "Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis". 134
Comment on “Oral lichenoid reaction in a psoriatic patient treated with secukinumab: A drug-related rather than a class-related adverse event?” 132
Cutaneous leukocytoclastic vasculitis in B-cell chronic lymphocytic leukaemia patients. 131
Thymoma-Associated Paraneoplastic Autoimmune Multiorgan Syndrome-From Pemphigus to Lichenoid Dermatitis 128
The role of trpa1 in skin physiology and pathology 125
Unilateral generalised morphea successfully treated with rituximab and mycophenolate mofetil 123
The skin doesn't lie: a case of dermatitis herpetiformis in the setting of refractory coeliac disease 123
Mucous membrane pemphigoid with lichen planus-like features: not only in the oral mucosa 123
Serration pattern analysis as a tool for the diagnosis of immunoglobulin A-mediated epidermolysis bullosa acquisita 122
Reply to "Comment on "Fatal occurrence of acquired haemophilia A in a patient with pemphigus vulgaris" 120
Propranolol Off-Target: A New Therapeutic Option in Neutrophil-Dependent Dermatoses? 119
Pemphigus: Current and Future Therapeutic Strategies 115
Assessment of serious infections in pemphigus and pemphigoid by a national registry 113
Is it really possible to cure hairy cell leukemia patients only with frontline therapy? 112
Reply to ‘Pruritic arthropod bite-like papules in T-cell large granular lymphocytic leukaemia and chronic myelomonocytic leukaemia’ 111
Visual Dermatology: Self-Induced Chronic Saxophone Penis Due to Paraffin Injections 106
Collection of hematopoietic stem cells after previous radioimmunotherapy is feasible and does not impair engraftment after autologous stem cell transplantation in follicular lymphoma 106
Improving the diagnosis of autoimmune blistering dermatoses of the oral mucosa 105
Targeted Therapies for Autoimmune Bullous Diseases: Current Status 103
Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma 99
Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients 94
Reply to 'Comments on the first European guideline for paraneoplastic autoimmune multiorgan syndrome' 93
Long-term outcome of patients with advanced-stage cutaneous T cell lymphoma treated with gemcitabine 91
Pathogenic relevance of antibodies against desmoglein 3 in patients with oral lichen planus 87
Pharmacological advances in pemphigoid 87
Pathogenetische Bedeutung von Antikörpern gegen Desmoglein 3 bei Patienten mit oralem Lichen planus 86
Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma 86
Pemphigus and pemphigoids: Clinical presentation, diagnosis and therapy 86
The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients 84
Nivolumab-induced erosive pustular dermatosis of the scalp 83
It is time to reconsider antibodies against integrin β4 in mucous membrane pemphigoid: Comment on 'Native collagen XVII complex ELISA: An approach for diagnosis and monitoring of anti-integrin β4 mucous membrane pemphigoid' 76
Role of autologous stem cell transplantation in T-cell lymphoma patients: a single institution retrospective analysis 74
High-throughput proteomics uncovers molecular clusters and biomarkers of severity in bullous pemphigoid 58
A 14-year multicentric follow-up study of atypical pemphigus variants in Italy: the VARIANT_P study 48
Oral Erosive Lichen Planus Successfully Treated with Baricitinib 41
BP230-Type Bullous Pemphigoid is a Rare Subset of Bullous Pemphigoid Associated With a Favorable Prognosis: A Retrospective Analysis From a Tertiary Referral Center 32
A Specific Signature of Circulating Free Fatty Acid Discriminates Bullous Pemphigoid From Pemphigus Vulgaris and Healthy Controls 31
Baricitinib improved morphoea manifestations in a patient with alopecia areata universalis 30
Safety, tolerability, pharmacokinetics and pharmacodynamic effects of desmoglein 3 peptide-coupled tolerizing nanoparticles in pemphigus 22
Dupilumab for Prurigo Nodularis: Real-World Outcomes Up to 104 Weeks from the DUPItaPN Study 22
Off-label use of tralokinumab in the treatment of bullous pemphigoid: a case series 17
The role of serological investigations in the diagnosis of bullous pemphigoid: a retrospective study 17
Management of Bullous Pemphigoid in Special Populations: A Narrative Review of the Literature 15
Hand Edema and waxy papular eruption: a dermatologic riddle 12
Peptide Epitopes of NC16A BP180 in the Diagnostics of Bullous Pemphigoid 11
Totale 12.027
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.584
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.584
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022300 6 40 40 16 3 22 7 27 14 14 36 75
2022/2023989 62 167 65 74 42 172 160 67 116 20 26 18
2023/2024697 27 44 93 39 43 108 29 137 25 73 58 21
2024/20254.308 134 386 202 509 1.121 723 123 178 227 269 178 258
2025/20264.877 453 743 735 496 405 111 432 188 287 312 175 540
2026/202750 50 0 0 0 0 0 0 0 0 0 0 0
Totale 12.027